Dynamic Healthcare M&A Database

Acquiring Party	ATS Medical, Inc. (Nasdaq: ATSI ), a manufacturer of heart valve and other cardiac surgery products and services.
Transferring Party	The surgical cryoablation business of CryoCath Technologies, Inc. (CYT.TO), a manufacturer of cryotherapy and catheter products to treat cardiovascular disease and cardiac arrhythmias.
Sector	Medical Devices
Date	June 28, 2007
Analysis Follows from an existing distribution agreement under which ATS successfully grew cryoblation revenue and market share. With the deal, ATS diversifies its product range and enhances its revenue and operating margins since it already has the selling, marketing and administrative infrastructure in place for CryoCath's products. The deal enables CryoCath to focus on its remaining electrophysiology line for treating atrial fibrillation and other arrhythmias. Deal value -- $22.0m plus up to $8.0 in contingent payments.
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason.

Dynamic Healthcare M&A Database - 2Q07